Daniel, C.P.; Wagner, M.J.; Borne, G.E.; Plaisance, C.J.; Ahmadzadeh, S.; Aquino, A.; Shekoohi, S.; Kaye, A.M.; Cornett, E.M.; Kaye, A.D.
Acromegaly: Pathophysiological Considerations and Treatment Options Including the Evolving Role of Oral Somatostatin Analogs. Pathophysiology 2023, 30, 377-388.
https://doi.org/10.3390/pathophysiology30030029
AMA Style
Daniel CP, Wagner MJ, Borne GE, Plaisance CJ, Ahmadzadeh S, Aquino A, Shekoohi S, Kaye AM, Cornett EM, Kaye AD.
Acromegaly: Pathophysiological Considerations and Treatment Options Including the Evolving Role of Oral Somatostatin Analogs. Pathophysiology. 2023; 30(3):377-388.
https://doi.org/10.3390/pathophysiology30030029
Chicago/Turabian Style
Daniel, Charles P., Maxwell J. Wagner, Grant E. Borne, Connor J. Plaisance, Shahab Ahmadzadeh, Alfonso Aquino, Sahar Shekoohi, Adam M. Kaye, Elyse M. Cornett, and Alan D. Kaye.
2023. "Acromegaly: Pathophysiological Considerations and Treatment Options Including the Evolving Role of Oral Somatostatin Analogs" Pathophysiology 30, no. 3: 377-388.
https://doi.org/10.3390/pathophysiology30030029
APA Style
Daniel, C. P., Wagner, M. J., Borne, G. E., Plaisance, C. J., Ahmadzadeh, S., Aquino, A., Shekoohi, S., Kaye, A. M., Cornett, E. M., & Kaye, A. D.
(2023). Acromegaly: Pathophysiological Considerations and Treatment Options Including the Evolving Role of Oral Somatostatin Analogs. Pathophysiology, 30(3), 377-388.
https://doi.org/10.3390/pathophysiology30030029
